Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001219 · ClinicalTrials.gov registry record
Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- 49,946
- Enrollment target
NCT00001219: Clinical Trial study, sponsored by National Institutes of Health Clinical Center (CC).
NCT00001219 is a clinical trial that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 49,946 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001219 was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- 49,946 participants
- Enrollment target
Study Summary
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patient s bodies or to monitor changes in the biochemistry and physiology of patient s bodies. Unlike other diagnostic techniques (CT scan and PET scan) MRI and MRS do not use ionizing radiation. Some studies have shown that MRI is more effective at distinguishing normal parts of the anatomy from abnormal anatomy, especially in the brain. MRI has become the diagnostic test of choice for evaluating patient with multiple sclerosis. The purpose of this study is to evaluate normal volunteers and patients with a variety of diseases with magnetic resonance imaging. Researchers will attempt different magnetic resonance imaging methods and techniques as well as different levels of magnetic strength.
Primary Outcome
clinically meaningful pulse sequence improvements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49,946 participants |
| Start Date | 1987-06-18 |
| Est. Completion | 2020-06-03 |
Why NCT00001219 stopped before completion
NCT00001219 is an observational study that tracks outcomes without assigning an intervention. Its 49,946 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001219 about?
NCT00001219 is a clinical study titled "Comparing Magnetic Resonance Imaging/Spectroscopy Techniques". Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patien...
What is the current status of trial NCT00001219?
This trial is currently terminated. The enrollment target is 49,946 participants. The study started on 1987-06-18. Estimated completion is 2020-06-03.
Who is sponsoring clinical trial NCT00001219?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI